Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Abate, Miseker
Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Miseker Abate
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Miseker Abate
Abbott, Andrea
Medical University of South Carolina
Breast Parallel Session 1
Location:Veterans Memorial Auditorium
Andrea Abbott
Abbott, Daniel
Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Daniel Abbott
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Daniel Abbott
Abbruzzese, James
Duke University Medical Center
P29: Hepatic resection for metastatic pancreatic ductal adenocarcinoma – a prospective single institution pilot study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
James Abbruzzese
Abdelfatah, Eihab
NYU Long Island School of Medicine
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Eihab Abdelfatah
Abdelrahman, Amro
Mayo Clinic
51: Response to neoadjuvant chemotherapy in invasive intraductal papillary mucinous cystic neoplasm compared to de novo pancreatic ductal adenocarcinoma
Location:Ballroom A
Amro Abdelrahman
P84: Outcomes After Minimally Invasive Gastrectomy for Locally Advanced Gastric Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Amro Abdelrahman
Abou-Alfa, Ghassan
Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Ghassan Abou-Alfa
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Ghassan Abou-Alfa
Abreu, Andres
UT Southwestern Medical Center
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Andres Abreu
P18: Perioperative Outcomes of Robotic and Laparoscopic Surgery for Colorectal Cancer: A Propensity Score Matched Analysis
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Andres Abreu
Ackerknecht, Markus
University of Basel, Basel, Switzerland; Department of Biomedicine, University Hospital Basel, Basel, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Markus Ackerknecht
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Markus Ackerknecht
Adam, Mohamed
University of California - San Francisco Medical Center
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Mohamed Adam
P56: A Data Driven Approach for Individualized Risk Prediction of Serious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Location:SSO HUB: Rare/Metastatic Cancers Zone
Mohamed Adam
Adams Greenup, Rachel
Yale School of Medicine
Financial Toxicity
Location:Ballroom A
Rachel Adams Greenup
Strategies to Increase Enrollment of Diverse Populations in Clinical Trials
Location:SSO HUB: Rare/Metastatic Cancers Zone
Rachel Adams Greenup
Adigbli, George
Nuffield Dept. of Surgical Sciences, University of Oxford
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
George Adigbli
Aggon, Allison
Fox Chase Cancer Center
14: Should patients with HR+HER2- breast cancer and 1-3 positive sentinel nodes undergo axillary dissection to determine candidacy for abemaciclib?
Location:Veterans Memorial Auditorium
Allison Aggon
Ahmad, Syed
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Syed Ahmad
Ahmed, Fasih Ali
University Hospitals, Cleveland Medical Center
P69: Understanding Factors Leading to Surgical Attrition for “Resectable” Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Fasih Ali Ahmed
Ahrendt, Gretchen
Department of Surgery, University of Colorado Anschutz Medical Campus
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
Gretchen Ahrendt
Ahrendt, Steven
University of Colorado Anschutz Medical Campus
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Steven Ahrendt
Aiken, Taylor
University of Wisconsin Hospitals and Clinics
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Taylor Aiken
Akmal, Sarfraz
National Cancer Institute | National Institutes of Health
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Sarfraz Akmal
Akumuo, Rita
Department of General Surgery, Temple University Hospital, Philadelphia, USA
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Rita Akumuo
Alaimo, Laura
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Laura Alaimo
Aldakkak, Mohammed
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Mohammed Aldakkak
Allen, Casey
Allegheny Health Network
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
Casey Allen
Initiating Value-Based Surgical Oncology Care in Your Institution: Prehab, ERAS, PROs, Costs & Research
Location:Ballroom A
Casey Allen
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Casey Allen
Questions and Discussion
Location:Ballroom A
Casey Allen
Allen, Peter
Duke University Medical Center
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Peter Allen
P29: Hepatic resection for metastatic pancreatic ductal adenocarcinoma – a prospective single institution pilot study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Peter Allen
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Peter Allen
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Peter Allen
Allen, Robert
Memorial Sloan Kettering Cancer Center
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Robert Allen
Almond, Max
University Hospital Birmingham NHS Foundation Trust
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Max Almond
Alobuia, Wilson
Stanford University School of Medicine
78: Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
Location:Ballroom A
Wilson Alobuia
Alterio, Rodrigo
University of Texas Southwestern Medical Center
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Rodrigo Alterio
Alyateem, George
New York Medical College - Metropolitan Hospital Center
P30: Validating a Genome-wide CRISPR Screen Determining Mechanisms of Drug Resistance in Pancreatic Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
George Alyateem
Alzhanova, Dina
UT Southwestern Medical Center, Dept of Surgery
49: Stroma Selective Inhibition of TGFβ – Genomic Stratification As The Key to Overcoming Failed Clinical Translation in Pancreatic Cancer
Location:Ballroom A
Dina Alzhanova
Amersi, Farin
Cedars Sinai Medical Center
15: A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 with Early Invasive ER+ Breast Cancer Undergoing Breast Conserving Surgery
Location:Veterans Memorial Auditorium
Farin Amersi
18: Clinical Impact of Semi-Annual Mammography in Patients Undergoing Breast Conserving Surgery Following Neoadjuvant Therapy
Location:Veterans Memorial Auditorium
Farin Amersi
32: Impact of Primary Tumor Resection on Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Location:Ballroom A
Farin Amersi
Amin, Miral
John Peter Smith Hospital, Fort Worth, Texas
Breast Parallel Session 1
Location:Veterans Memorial Auditorium
Miral Amin
Amirfakhri, Siamak
VA San Diego Healthcare System
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Siamak Amirfakhri
Amjad, Wajid
University of Pennsylvania Health System
P23: Resection of the Primary Tumor Improves Survival in Metastatic Adrenocortical Carcinoma
Location:SSO HUB: Breast & Endocrine Zone
Wajid Amjad
Ammori, John
University Hospitals Cleveland Medical Center/Case Western Reserve University
31: Factors Predicting Immunotherapy Utilization for Metastatic Merkel Cell Carcinoma from 2015-2018
Location:Ballroom A
John Ammori
P69: Understanding Factors Leading to Surgical Attrition for “Resectable” Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
John Ammori
Anaya, Daniel
Moffitt Cancer Center
Questions and Discussion
Location:Ballroom B
Daniel Anaya
When the Liver Remnant is Too Small: Measure of FLR, Alpps, Pve, and their Oncologic Considerations
Location:Ballroom B
Daniel Anaya
Ancha, Bhavya
Perelman School of Medicine, University of Pennsylvania
P67: Neighborhood Deprivation and Breast Cancer Outcomes in Philadelphia
Location:SSO HUB: Rare/Metastatic Cancers Zone
Bhavya Ancha
Andersen, Barbara
The Ohio State University Department of Psychology
P5: Allostatic Load as a New Predictor of Postoperative Complications in Oncology Patients
Location:SSO HUB: Breast & Endocrine Zone
Barbara Andersen
Angeles, Christina
University of Michigan, Rogel Cancer Center
2018-2020 Clinical Investigator Award-Characterization of Skin Resident Memory T Cells in Melanoma Survivors
Location:Ballroom C
Christina Angeles
Antonescu, Cristina
Department of Pathology
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Cristina Antonescu
Aoun, Rami James
Department of Surgery, The Ohio State Wexner Medical Center
P13: Multiomic Profile of Colorectal Cancer Cell Line Radiosensitivity
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Rami James Aoun
Aquina, Christopher
AdventHealth Orlando
67: Molecular mechanism of colorectal peritoneal metastasis: an interesting TWIST
Location:Ballroom B
Christopher Aquina
85: Impact of Incident Hospital-Acquired Geriatric Syndromes on Short-term Outcomes following Gastrointestinal Cancer Resection
Location:Ballroom B
Christopher Aquina
Araujo Lima, Henrique
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
34: An Artificial Intelligence Approach to Determining Optimal Margin Width in Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma
Location:Veterans Memorial Auditorium
Henrique Araujo Lima
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Henrique Araujo Lima
Are, Chandrakanth
University of Nebraska Medical Center
Multidisciplinary Management of Cancer Globally
Location:Room 302
Chandrakanth Are
Arenberger, Petr
Charles University Third Faculty of Medicine and University Hospital of Královské Vinohrady
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Petr Arenberger
Ariyan, Charlotte
Memorial Sloan Kettering Cancer Center
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Charlotte Ariyan
PeerView Independent Satellite Symposium: Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies
Location:Room 302
Charlotte Ariyan
Questions and Discussion
Location:Ballroom C
Charlotte Ariyan
Stage IV (Timing/PT Selection, Are We Actually Operating More Frequently?)
Location:Ballroom C
Charlotte Ariyan
Arrington, Amanda
Houston Methodist Hospital
Surg Onc
Location:SSO HUB Theater
Amanda Arrington
Asare, Elliot
University of Utah and Huntsman Cancer Institute
Skin Cancers in Pigmented Skin - Melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Elliot Asare
Ascierto, Paolo
Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Paolo Ascierto
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Paolo Ascierto
Ashamalla, shady
University of Toronto
P16: The role of anastomotic leak as a potential high-risk criteria in Stage II colon cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
shady Ashamalla
Asher, Stephanie
University of Pennsylvania, Medical Genetics
P25: What are the clinical implications of SDHA pathogenic variants?
Location:SSO HUB: Breast & Endocrine Zone
Stephanie Asher
Ashman, Jonathan
Mayo Clinic Arizona
P63: Is there a benefit to radiation and surgery in specific histologic subtypes of retroperitoneal sarcoma?
Location:SSO HUB: Melanoma & Sarcoma Zone
Jonathan Ashman
Assumpção, Lia
Department of Surgery, Rio de Janeiro State University, Rio de Janeiro, Brazil
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Lia Assumpção
Astsaturov, Igor
Fox Chase Cancer Center
50: Anti-Netrin-1 Therapy Inhibits Metastasis and Improves Survival in Pancreatic Cancer
Location:Ballroom A
Igor Astsaturov
Atabek, Umur
Cooper University Hospital Department of Surgery
10: Epigenetic Drug Therapy Increases Immune Activation and Expression of Genes in the Oncotype Dx Score in Breast Cancer
Location:Veterans Memorial Auditorium
Umur Atabek
Attwood, Kristopher
Roswell Park Comprehensive Cancer Center
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Kristopher Attwood
Auer, Paul
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
Paul Auer
Augustine, Mathew
UTSW
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Mathew Augustine
Aushev, Vasily
Natera
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Vasily Aushev
Axelrod, Bayley
Memorial Sloan Kettering Cancer Center
P3: Diagnosing lymphedema after axillary surgery: which method is superior?
Location:SSO HUB: Breast & Endocrine Zone
Bayley Axelrod
Ayabe, Reed
MD Anderson Cancer Center
36: KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis
Location:Veterans Memorial Auditorium
Reed Ayabe
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Reed Ayabe
Azap, Lovette
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center
80: Disparities in Socioeconomic Mediation of Racial Segregation in Hepatopancreaticobiliary Cancer
Location:Veterans Memorial Auditorium
Lovette Azap
Back to Top
